MedTrace Logo

Effects of Red Wine and Cognac on Coronary Circulation

NCT00330213 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2006-05-26

No results posted yet for this study

Summary

Red wine consumption is associated with reduced cardiovascular disease mortality, and the cardioprotective properties may be partly related to its ability to improve endothelial function. The purpose of this study was to determine whether moderate doses of red wine, de-alcoholized red wine and cognac improve coronary flow reserve.

Conditions

  • Healthy

Interventions

BEHAVIORAL

red wine and cognac consumption

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Tuomas O Kiviniemi, MD · Dept. Clinical Physiology and Nuclear Medicine, Turku University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Completion
2005-04-30

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00330213 on ClinicalTrials.gov